The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Oncolytic viruses
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993) · Cell · doi:10.1016/0092-8674(93)90231-e · Cited by 2,199
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., et al. (1996) · Science · doi:10.1126/science.274.5286.373 · Cited by 1,760
Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., et al. (2000) · Nature Medicine · doi:10.1038/78638 · Cited by 1,101
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Martuza, R. L., Malick, A., Markert, J. M., Ruffner, K. L., & Coen, D. M. (1991) · Science · doi:10.1126/science.1851332 · Cited by 1,050
Markert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D., Palmer, C. A., Feigenbaum, F., Tornatore, C., Tufaro, F., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301205 · Cited by 976
DeGregori, J., Kowalik, T., & Nevins, J. R. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4215 · Cited by 919
Geraghty, R. J., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., & Spear, P. G. (1998) · Science · doi:10.1126/science.280.5369.1618 · Cited by 909
Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas
Mineta, T., Rabkin, S. D., Yazaki, T., Hunter, W. D., & Martuza, R. L. (1995) · Nature Medicine · doi:10.1038/nm0995-938 · Cited by 822
PKR; a sentinel kinase for cellular stress
Williams, B. R. (1999) · Oncogene · doi:10.1038/sj.onc.1203127 · Cited by 820
Stojdl, D. F., Lichty, B., Knowles, S., Marius, R., Atkins, H., Sonenberg, N., & Bell, J. C. (2000) · Nature Medicine · doi:10.1038/77558 · Cited by 815
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
Fueyo, J., Gomez-Manzano, C., Alemany, R., Lee, P. S., McDonnell, T. J., Mitlianga, P., Shi, Y.-X., Levin, V. A., Yung, W. K. A., & Kyritsis, A. P. (2000) · Oncogene · doi:10.1038/sj.onc.1203251 · Cited by 764
He, B., Gross, M., & Roizman, B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.843 · Cited by 751
Reovirus Therapy of Tumors with Activated Ras Pathway
Coffey, M. C., Strong, J. E., Forsyth, P. A., & Lee, P. W. K. (1998) · Science · doi:10.1126/science.282.5392.1332 · Cited by 750
Inhibition of the Interferon- Inducible Protein Kinase PKR by HCV E2 Protein
Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N., & Lai, M. M. C. (1999) · Science · doi:10.1126/science.285.5424.107 · Cited by 733
Binding and modulation of p53 by p300/CBP coactivators
Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., & Livingston, D. M. (1997) · Nature · doi:10.1038/42981 · Cited by 693
Rampling, R., Cruickshank, G., Papanastassiou, V, Nicoll, J., Hadley, D., Brennan, D., Petty, R., MacLean, A., Harland, J., McKie, E., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301184 · Cited by 598
Rodríguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W., & Henderson, D. (1997) · PubMed · Cited by 584
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
Heise, C., Hermiston, T., Johnson, L., Brooks, G., Sampson-Johannes, A., Williams, A., Hawkins, L., & Kirn, D. (2000) · Nature Medicine · doi:10.1038/80474 · Cited by 583
Mechanism of activation of early viral transcription by the adenovirus E1A gene product
Nevins, J. R. (1981) · Cell · doi:10.1016/0092-8674(81)90304-4 · Cited by 573
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry
Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13799 · Cited by 567
Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein
Yew, P. R., & Berk, A. J. (1992) · Nature · doi:10.1038/357082a0 · Cited by 561
The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus
Strong, J. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3351 · Cited by 552
Bioluminescent indicators in living mammals
Contag, P. R., Olomu, I. N., Stevenson, D. K., & Contag, C. H. (1998) · Nature Medicine · doi:10.1038/nm0298-245 · Cited by 517
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
Todo, T., Martuza, R. L., Rabkin, S. D., & Johnson, P. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101136398 · Cited by 465
REGRESSION OF BURKITT'S LYMPHOMA IN ASSOCIATION WITH MEASLES INFECTION
Bluming, A., & Ziegler, J. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92086-1 · Cited by 410
LU, Y., WAMBACH, M., KATZE, M. G., & KRUG, R. M. (1995) · Virology · doi:10.1006/viro.1995.9937 · Cited by 387
DeWeese, T. L., van der Poel, H. G., Li, S., Mikhak, B., Drew, R., Goemann, M., Hamper, U. M., DeJong, R., Detorie, N. A., Rodríguez, R., et al. (2001) · PubMed · Cited by 385
Pecora, A. L., Rizvi, N., Cohen, G. I., Meropol, N. J., Sterman, D., Marshall, J. L., Goldberg, S., Gross, P., O’Neil, J. D., Groene, W. S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.042 · Cited by 385
Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryerse, J. S., Wold, L. J., & Wold, W. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2296-2306.1996 · Cited by 375
McCart, J. A., Ward, J. M., Lee, J., Hu, Y., Alexander, H. R., Libutti, S. K., Moss, B., & Bartlett, D. L. (2001) · PubMed · Cited by 366
Kitajewski, J., Schneider, R. J., Safer, B., Munemitsu, S. M., Samuel, C. E., Thimmappaya, B., & Shenk, T. (1986) · Cell · doi:10.1016/0092-8674(86)90383-1 · Cited by 363
Intergeneric poliovirus recombinants for the treatment of malignant glioma
Gromeier, M., Lachmann, S., Rosenfeld, M. R., Gutin, P. H., & Wimmer, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6803 · Cited by 363
Barth, R. F. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005805203044 · Cited by 353
Kirn, D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301377 · Cited by 349
Ikeda, K., Ichikawa, T., Wakimoto, H., Silver, J. S., Deisboeck, T. S., Finkelstein, D., Harsh, G. R., Louis, D. N., Bartus, R. T., Hochberg, F. H., et al. (1999) · Nature Medicine · doi:10.1038/11320 · Cited by 339
A Viral Mechanism for Inhibition of p300 and PCAF Acetyltransferase Activity
Chakravarti, D., Ogryzko, V., Kao, H.-Y., Nash, A., Chen, H., Nakatani, Y., & Evans, R. M. (1999) · Cell · doi:10.1016/s0092-8674(00)80552-8 · Cited by 339
Freytag, S. O., Rogulski, K. R., Paielli, D. L., Gilbert, J. D., & Kim, J. H. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.9-1323 · Cited by 337
Parker, J. N., Gillespie, G. Y., Love, C. E., Randall, S., Whitley, R. J., & Markert, J. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040557897 · Cited by 332
Papanastassiou, V, Rampling, R., Fraser, M., Petty, R., Hadley, D., Nicoll, J., Harland, J., Mabbs, R., & Brown, M. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301664 · Cited by 328
Ribonucleotide reductase: regulation, regulation, regulation
Elledge, S. J., Zhou, Z., & Allen, J. B. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90249-9 · Cited by 309
p53 Status Does Not Determine Outcome of E1B 55-Kilodalton Mutant Adenovirus Lytic Infection
Goodrum, F. D., & Ornelles, D. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9479-9490.1998 · Cited by 289
Davies, M. V., Chang, H. W., Jacobs, B. L., & Kaufman, R. J. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1688-1692.1993 · Cited by 274
p53-Independent and -Dependent Requirements for E1B-55K in Adenovirus Type 5 Replication
Harada, J. N., & Berk, A. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5333-5344.1999 · Cited by 259
Meignier, B., Longnecker, R., & Roizman, B. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.3.602 · Cited by 248
Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1
Farassati, F., Yang, A.-D., & Lee, P. W. K. (2001) · Nature Cell Biology · doi:10.1038/35087061 · Cited by 236
Hemmi, S., Geertsen, R., Mezzacasa, A., Peter, I., & Dummer, R. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.16-2363 · Cited by 234
Wong, L. H., Krauer, K. G., Hatzinisiriou, I., Estcourt, M. J., Hersey, P., Tam, N. D., Edmondson, S., Devenish, R. J., & Ralph, S. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28779 · Cited by 234
p53-dependent cell death/apoptosis is required for a productive adenovirus infection
Hall, A. R., Dix, B. R., O’Carroll, S. J., & Braithwaite, A. W. (1998) · Nature Medicine · doi:10.1038/2057 · Cited by 231
Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene
Leib, D. A., Machalek, M. A., Williams, B. R. G., Silverman, R. H., & Virgin, H. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100415697 · Cited by 230
Two regions of the adenovirus early region 1A proteins are required for transformation
Whyte, P., Ruley, H. E., & Harlow, E. (1988) · Journal of Virology · doi:10.1128/jvi.62.1.257-265.1988 · Cited by 226
Goldstein, D. J., & Weller, S. K. (1988) · Virology · doi:10.1016/0042-6822(88)90144-4 · Cited by 226
Reovirus as an Oncolytic Agent Against Experimental Human Malignant Gliomas
Wilcox, M. E., Yang, W., Senger, D. L., Rewcastle, N. B., Morris, D. G., Brasher, P. M. A., Shi, Z. Q., Johnston, R. N., Nishikawa, S., Lee, P. W. K., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.12.903 · Cited by 218
Treatment of human cancer with mumps virus
Asada, T. (1974) · Cancer · doi:10.1002/1097-0142(197412)34:6<1907::aid-cncr2820340609>3.0.co;2-4 · Cited by 213
Sarnow, P., Hearing, P., Anderson, C. W., Halbert, D. N., Shenk, T., & Levine, A. J. (1984) · Journal of Virology · doi:10.1128/jvi.49.3.692-700.1984 · Cited by 211
Virus-mediated killing of cells that lack p53 activity
Raj, K., Ogston, P., & Beard, P. (2001) · Nature · doi:10.1038/35091082 · Cited by 207
Johnson, L., Shen, A., Boyle, L., Kunich, J., Pandey, K., Lemmon, M., Hermiston, T., Giedlin, M., McCormick, F., & Fattaey, A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00060-0 · Cited by 191
Hunter, W. D., Martuza, R. L., Feigenbaum, F., Todo, T., Mineta, T., Yazaki, T., Toda, M., Newsome, J. T., Platenberg, R. C., Manz, H. J., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6319-6326.1999 · Cited by 191
Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)
Ries, S. J., Brandts, C. H., Chung, A. S., Biederer, C. H., Hann, B. C., Lipner, E. M., McCormick, F., & Michael Korn, W. (2000) · Nature Medicine · doi:10.1038/80466 · Cited by 189
Markert, J. M., Malick, A., Coen, D. M., & Martuza, R. L. (1993) · Neurosurgery · doi:10.1097/00006123-199304000-00016 · Cited by 187
Chase, M., Chung, R. Y., & Chiocca, E. A. (1998) · Nature Biotechnology · doi:10.1038/nbt0598-444 · Cited by 178
Reovirus Oncolysis of Human Breast Cancer
Norman, K. L., Coffey, M. C., Hirasawa, K., Demetrick, D. J., Nishikawa, S. G., DiFrancesco, L. M., Strong, J. E., & Lee, P. W. K. (2002) · Human Gene Therapy · doi:10.1089/10430340252837233 · Cited by 174
Kramm, C. M., Chase, M., Herrlinger, U., Jacobs, A., Pechan, P. A., Rainov, N. G., Sena-Esteves, M., Aghi, M., Barnett, F. H., Chiocca, E. A., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.17-2057 · Cited by 167
Leppard, K. N., & Shenk, T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08360.x · Cited by 166
Chen, Y., DeWeese, T. L., Dilley, J., et al. (2001) · PubMed · Cited by 163
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides
Peng, K.-W., Facteau, S., Wegman, T., O'Kane, D., & Russell, S. J. (2002) · Nature Medicine · doi:10.1038/nm0502-527 · Cited by 162
Toda, M., Martuza, R. L., Kojima, H., & Rabkin, S. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4457 · Cited by 161
Boviatsis, E., Chase, M., Wei, M., Tamiya, T., Hurford, R. K., Kowall, N. W., Tepper, R. I., Breakefield, X. O., & Chiocca, E. A. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.2-183 · Cited by 156
Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.
Lorence, R. M., Katubig, B. B., Reichard, K. W., Reyes, H. M., Phuangsab, A., Sassetti, M., Walter, R. J., & Peeples, M. E. (1994) · PubMed · Cited by 156
Ikeda, K., Wakimoto, H., Ichikawa, T., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4765-4775.2000 · Cited by 154
Jacobs, A., Tjuvajev, J. G., Dubrovin, M., Akhurst, T., Balatoni, J., Beattie, B. J., Joshi, R., Finn, R., Larson, S. M., Herrlinger, U., et al. (2001) · PubMed · Cited by 153
Herrlinger, U., Woiciechowski, C., Sena‐Esteves, M., Aboody, K. S., Jacobs, A. H., Rainov, N. G., Snyder, E. Y., & Breakefield, X. O. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0046 · Cited by 152
Andreansky, S. S., Soroceanu, L., Er, F., Chou, J., Markert, J. M., Gillespie, G. Y., Roizman, B., & Whitley, R. J. (1997) · PubMed · Cited by 148
Li, Y., Yu, D., Chen, Y., Amin, P. R., Zhang, H., Nguyen, N., & Henderson, D. (2001) · PubMed · Cited by 147
Chen, Y., Yu, D., Charlton, D., & Henderson, D. (2000) · Human Gene Therapy · doi:10.1089/10430340050083289 · Cited by 143
Aghi, M. K., Cho, T.-C., Chiocca, E. A., Kramm, C. M., & Breakefield, X. O. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.5.370 · Cited by 143
He, B., Chou, J., Brandimarti, R., Mohr, I., Gluzman, Y., & Roizman, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.6049-6054.1997 · Cited by 142
Cytokine Gene Transfer Enhances Herpes Oncolytic Therapy in Murine Squamous Cell Carcinoma
Wong, R. J., Patel, S. G., Kim, S., et al. (2001) · Human Gene Therapy · doi:10.1089/10430340150218396 · Cited by 135
Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy
Ramachandra, M., Rahman, A., Zou, A., et al. (2001) · Nature Biotechnology · doi:10.1038/nbt1101-1035 · Cited by 134
Deb, A., Haque, S. J., Mogensen, T. H., Silverman, R. H., & Williams, B. R. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6170 · Cited by 123
Toyoizumi, T., Mick, R., Abbas, A. E., Kang, E. H., Kaiser, L. R., & Molnar-Kimber, K. L. (1999) · Human Gene Therapy · doi:10.1089/10430349950016410 · Cited by 120
Ej, B., Jm, S., Chase, M. R., et al. (1994) · PubMed · Cited by 116
Chung, R. Y., Saeki, Y., & Chiocca, E. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7556-7564.1999 · Cited by 115
Yoon, S. S., Nakamura, H., Carroll, N. M., Bode, B. P., Chiocca, E. A., & Tanabe, K. K. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.2.301 · Cited by 110
Nanda, D., Vogels, R., Havenga, M. J. E., Avezaat, C. J. J., Bout, A., & Smitt, P. A. E. S. (2001) · PubMed · Cited by 110
Harsh, G. R., Deisboeck, T. S., Louis, D. N., et al. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.92.5.0804 · Cited by 109
Coukos, G., Makrigiannakis, A., Kang, E. H., Caparelli, D., Benjamin, I., Kaiser, L. R., Rubin, S. C., Albelda, S. Μ., & Molnar-Kimber, K. L. (1999) · PubMed · Cited by 108
McCart, J., Puhlmann, M., Lee, J. K., Hu, Y., Libutti, S. K., Alexander, H., & BARTLETT, D. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301237 · Cited by 94
Nakamura, H., Mullen, J. T., Chandrasekhar, S., Pawlik, T. M., Yoon, S. S., & Tanabe, K. K. (2001) · PubMed · Cited by 93
The Complement Response Against an Oncolytic Virus Is Species-Specific in Its Activation Pathways
Wakimoto, H., Ikeda, K., Abé, T., et al. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0547 · Cited by 93
Mohr, I., Sternberg, D., Ward, S., Leib, D. A., Mulvey, M. A., & Gluzman, Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5189-5196.2001 · Cited by 91
Zhang, J. F., Hu, C., Geng, Y., Selm, J., Klein, S., Orazi, A., & Taylor, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4513 · Cited by 88
Terry-Allison, T., Montgomery, R. I., Whitbeck, J. C., Xu, R., Cohen, G. H., Eisenberg, R. J., & Spear, P. G. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.5802-5810.1998 · Cited by 87
Cancer Gene Therapy Using a Replication-Competent Herpes Simplex Virus Type 1 Vector
Yoon, S. S., Carroll, N. M., Chiocca, E. A., & Tanabe, K. K. (1998) · Annals of Surgery · doi:10.1097/00000658-199809000-00009 · Cited by 86
Yew, P. R., Kao, C. C., & Berk, A. J. (1990) · Virology · doi:10.1016/0042-6822(90)90147-j · Cited by 84
HIV-I TAT Inhibits PKR Activity by Both RNA-Dependent and RNA-Independent Mechanisms
Cai, R., Carpick, B. W., Chun, R. F., Jeang, K.-T., & Williams, B. R. G. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1583 · Cited by 83
Platelet-derived Growth Factor Signal Transduction through the Interferon-inducible Kinase PKR
Mundschau, L. J., & Faller, D. V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3100 · Cited by 79
Therapy of Head and Neck Squamous Cell Carcinoma with an Oncolytic Adenovirus Expressing HSV-tk
Morris, J. C., & Wildner, O. (2000) · Molecular Therapy · doi:10.1006/mthe.1999.0014 · Cited by 75
Zhang, J., Ramesh, N., Chen, Y., Li, Y., Dilley, J., Working, P. K., & Yu, D. (2002) · PubMed · Cited by 68
Balagué, C., Noya, F., Alemany, R., Chow, L. T., & Curiel, D. T. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7602-7611.2001 · Cited by 66
DNA Replication of First-Generation Adenovirus Vectors in Tumor Cells
Steinwaerder, D. S., Carlson, C. A., & Lieber, A. (2000) · Human Gene Therapy · doi:10.1089/10430340050129549 · Cited by 65
Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector
Steinwaerder, D. S., Carlson, C. A., Otto, D. L., et al. (2001) · Nature Medicine · doi:10.1038/84696 · Cited by 54
The Effect of Ganciclovir on Herpes Simplex Virus-Mediated Oncolysis
Carroll, N. M., Chase, M. R., Chiocca, E. A., et al. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1997.5089 · Cited by 50
Petrowsky, H., Roberts, G. D., Kooby, D. A., Burt, B. M., Bennett, J., Delman, K. A., Stanziale, S. F., Delohery, T. M., Tong, W. P., Federoff, H. J., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7050-7058.2001 · Cited by 47
Quantitation of HSV mass distribution in a rodent brain tumor model
Schellingerhout, D., Rainov, N. G., Breakefield, X. O., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301272 · Cited by 45
ONYX-015 selectivity and the p14ARF pathway
McCormick, F. P. (2000) · Oncogene · doi:10.1038/sj.onc.1204096 · Cited by 43
A Novel ‘Piggyback’ Packaging System for Herpes Simplex Virus Amplicon Vectors
Pechan, P. A., Fotaki, M. E., Thompson, R., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.16-2003 · Cited by 31
Cited by
The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
Kwon, J., & Bakhoum, S. F. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0761 · Cited by 1,293
Heo, J., Reid, T., Ruo, L., Breitbach, C. J., Rose, S., Bloomston, M., Cho, M., Lim, H. Y., Chung, H. C., Kim, C. W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3089 · Cited by 779
McFadden, G. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1099 · Cited by 523
Chiocca, E. A., Abbed, K. M., Tatter, S., Louis, D. N., Hochberg, F. H., Barker, F., Kracher, J., Grossman, S. A., Fisher, J. D., Carson, K., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.021 · Cited by 436
Precise nanomedicine for intelligent therapy of cancer
Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 409
Metadata
- Authors
- Antonio Chiocca, E.
- Venue
- Nature Reviews Cancer
- Published
- 2002-12-01
- Volume
- 2
- Issue
- 12
- Pages
- 938-950
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W4211126864
- Cited by
- 306
- References
- 107
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.